Edwards Lifesciences Corp Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2022 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Edwards Lifesciences Corp quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2022 to Q2 2024.
  • Edwards Lifesciences Corp Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was $366M, a 19.3% increase year-over-year.
  • Edwards Lifesciences Corp Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was $1.47B.
  • Edwards Lifesciences Corp annual Net Income (Loss) Attributable to Parent for 2023 was $1.4B, a 7.85% decline from 2022.
  • Edwards Lifesciences Corp annual Net Income (Loss) Attributable to Parent for 2022 was $1.52B, a 1.25% increase from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $1.47B $366M +$59.2M +19.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-31
Q1 2024 $1.41B $352M +$11.4M +3.35% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-29
Q4 2023 $1.4B $370M Oct 1, 2023 Dec 31, 2023 10-K 2024-02-12
Q3 2023 $385M +$41.4M +12.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-10-27
Q2 2023 $307M -$99.3M -24.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-31
Q1 2023 $341M Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-29
Q3 2022 $344M Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-27
Q2 2022 $406M Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.